KalVista Pharmaceuticals (KALV) Payables: 2014-2024
Historic Payables for KalVista Pharmaceuticals (KALV) over the last 6 years, with Dec 2024 value amounting to $5.7 million.
- KalVista Pharmaceuticals' Payables was N/A to $5.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $30.8 million, marking a year-over-year change of. This contributed to the annual value of $9.1 million for FY2024, which is N/A change from last year.
- Latest data reveals that KalVista Pharmaceuticals reported Payables of $5.7 million as of Q4 2024, which was up 10.16% from $5.2 million recorded in Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Payables registered a high of $10.8 million during Q3 2024, and its lowest value of $641,000 during Q1 2021.
- Moreover, its 2-year median value for Payables was $5.2 million (2024), whereas its average is $6.3 million.
- As far as peak fluctuations go, KalVista Pharmaceuticals' Payables slumped by 78.28% in 2021, and later soared by 113.28% in 2024.
- Quarterly analysis of 4 years shows KalVista Pharmaceuticals' Payables stood at $2.2 million in 2020, then tumbled by 78.28% to $641,000 in 2021, then reached $4.9 million in 2023, then climbed by 6.17% to $5.7 million in 2024.
- Its Payables stands at $5.7 million for Q4 2024, versus $5.2 million for Q4 2024 and $10.8 million for Q3 2024.